Paul-Ehrlich-Institut

Springe direkt zu:

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Gardasil 9

Produktbeschreibung

9-valenter Humaner Papillom­virusimpfstoff

(Typen 6, 11, 16, 18, 31, 33, 45, 52, 58)

Verwendung ab einem Lebensalter von 9 Jahren / Use from 9 years of age onwards

Zulassungsinhaber Merck Sharp & Dohme B.V.

Zulassungsnummer EU/1/15/1007

Zulassungsdatum10.06.2015

Typ Monokomponentenimpfstoff

Krankheiten: Gebärmutterhalskrebs

Weitere Informationen

EPAR: Gardasil 9

Sicherheitsinformationen